{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:30:02Z","timestamp":1789684202547,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R15HL135700-01A1"],"award-info":[{"award-number":["1R15HL135700-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Patient Education and Counseling"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.pec.2023.108073","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T04:39:51Z","timestamp":1700195991000},"page":"108073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Trajectories of adherence to ACEI\/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas"],"prefix":"10.1016","volume":"119","author":[{"given":"Zahra","family":"Majd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilqees","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekere J.","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Abughosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pec.2023.108073_bib1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.118.11769","article-title":"Macrovasculature and microvasculature at the crossroads between type 2 diabetes mellitus and hypertension","volume":"73","author":"Climie","year":"2019","journal-title":"Hypertens"},{"key":"10.1016\/j.pec.2023.108073_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.pec.2023.108073_bib3","doi-asserted-by":"crossref","DOI":"10.5888\/pcd17.190058","article-title":"Peer reviewed: evidence-based interventions for high blood pressure and glycemic control among illinois health systems","volume":"17","author":"Price","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.pec.2023.108073_bib4","doi-asserted-by":"crossref","unstructured":"Association AD. 6. Glycemic targets: standards of medical care in diabetes\u20142021. Diabetes Care. 2021;44:S73-S84. http:\/\/dx.doi.org\/10.2337\/dc21-S006.","DOI":"10.2337\/dc21-S006"},{"key":"10.1016\/j.pec.2023.108073_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41440-017-0008-y","article-title":"Hypertension with diabetes mellitus complications","volume":"41","author":"Yamazaki","year":"2018","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pec.2023.108073_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pec.2023.108073_bib7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(21)01920-6","article-title":"Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis","volume":"398","author":"Nazarzadeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.pec.2023.108073_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.HYP.0000161880.59963.da","article-title":"Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension","volume":"45","author":"Doulton","year":"2005","journal-title":"Hypertens"},{"key":"10.1016\/j.pec.2023.108073_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253492","article-title":"Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials","volume":"16","author":"Yao","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.pec.2023.108073_bib10","unstructured":"Swislocki A.L., Siegel D. Managing Hypertension in Patients with Diabetes. Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications: IntechOpen; 2011."},{"key":"10.1016\/j.pec.2023.108073_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pec.2023.108073_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/HYPERTENSIONAHA.118.12495","article-title":"Antihypertensive medication nonpersistence and low adherence for adults< 65 years initiating treatment in 2007\u20132014","volume":"74","author":"Tajeu","year":"2019","journal-title":"Hypertens"},{"key":"10.1016\/j.pec.2023.108073_bib13","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/PPA.S270809","article-title":"Group-based trajectory modeling to identify patterns of adherence and its predictors among older adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)\/Angiotensin Receptor Blockers (ARBs)","author":"Paranjpe","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.pec.2023.108073_bib14","article-title":"Factors affecting medication adherence trajectories for patients with heart failure","volume":"21","author":"Juarez","year":"2015","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.pec.2023.108073_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.863876","article-title":"Assessing concurrent adherence to combined essential medication and clinical outcomes in patients with acute coronary syndrome. a population-based, real-world study using group-based trajectory models","volume":"9","author":"Rodr\u00edguez-Bernal","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pec.2023.108073_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.15585\/mmwr.mm6645a2","article-title":"CDC grand rounds: improving medication adherence for chronic disease management\u2014innovations and opportunities","volume":"66","author":"Neiman","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.pec.2023.108073_bib17","first-page":"43","article-title":"Nonadherence with ACE inhibitors is common and can be detected in clinical practice by routine serum ACE activity","volume":"7","author":"Struthers","year":"2001","journal-title":"CHF"},{"key":"10.1016\/j.pec.2023.108073_bib18","first-page":"527","article-title":"Nonadherence to angiotensin-converting enzyme inhibitors and\/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs","volume":"50","author":"Yang","year":"2010","journal-title":"JAPhA"},{"key":"10.1016\/j.pec.2023.108073_bib19","first-page":"1138","article-title":"Medication adherence trajectories: a systematic literature review","volume":"26","author":"Alhazami","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.pec.2023.108073_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/ajh\/hpx086","article-title":"Antihypertensive adherence trajectories among older adults in the first year after initiation of therapy","volume":"30","author":"Hargrove","year":"2017","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pec.2023.108073_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence","author":"Franklin","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.pec.2023.108073_bib22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11606-016-3747-6","article-title":"Trajectories of diabetes medication adherence and hospitalization risk: a retrospective cohort study in a large state Medicaid program","volume":"31","author":"Lo-Ciganic","year":"2016","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pec.2023.108073_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pds.3787","article-title":"Association between trajectories of statin adherence and subsequent cardiovascular events","volume":"24","author":"Franklin","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.pec.2023.108073_bib24","first-page":"305","article-title":"Motivational interviewing: a systematic review and meta-analysis","volume":"55","author":"Rubak","year":"2005","journal-title":"Br J Gen Pr"},{"key":"10.1016\/j.pec.2023.108073_bib25","first-page":"157","article-title":"Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials","volume":"93","author":"Lundahl","year":"2013","journal-title":"PEC"},{"key":"10.1016\/j.pec.2023.108073_bib26","first-page":"589","article-title":"Effectiveness of motivational interviewing interventions on medication adherence in adults with chronic diseases: a systematic review and meta-analysis","volume":"46","author":"Zomahoun","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.pec.2023.108073_bib27","first-page":"1","article-title":"A motivational interviewing intervention to improve adherence to aceis\/arbs among nonadherent older adults with comorbid hypertension and diabetes","author":"Mohan","year":"2023","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pec.2023.108073_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ahj.2013.09.014","article-title":"Untangling the relationship between medication adherence and post\u2013myocardial infarction outcomes: medication adherence and clinical outcomes","volume":"167","author":"Choudhry","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.pec.2023.108073_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.pec.2023.108073_bib30","article-title":"How to use SAS\u00ae Proc Traj and SAS\u00ae Proc Glimmix in respiratory epidemiology","author":"Arrandale","year":"2006","journal-title":"UBC,Vanc, Can"},{"key":"10.1016\/j.pec.2023.108073_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.pec.2023.108073_bib32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cpt.865","article-title":"Group\u2010based trajectory models: assessing adherence to antihypertensive medication in older adults in a community pharmacy setting","volume":"103","author":"Dillon","year":"2018","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.pec.2023.108073_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09540120701593489","article-title":"Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study","volume":"20","author":"DiIorio","year":"2008","journal-title":"AIDS Care"},{"key":"10.1016\/j.pec.2023.108073_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ajh.2008.240","article-title":"A practice-based trial of motivational interviewing and adherence in hypertensive African Americans","volume":"21","author":"Ogedegbe","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pec.2023.108073_bib35","first-page":"549","article-title":"A motivational interviewing intervention by pharmacy students to improve medication adherence","volume":"23","author":"Abughosh","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.pec.2023.108073_bib36","first-page":"1053","article-title":"Enhancing statin adherence using a motivational interviewing intervention and past adherence trajectories in patients with suboptimal adherence","volume":"25","author":"Abughosh","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.pec.2023.108073_bib37","first-page":"892","article-title":"Evaluating trajectories of statin adherence after a motivational interviewing intervention","volume":"60","author":"Paranjpe","year":"2020","journal-title":"JAPhA"},{"key":"10.1016\/j.pec.2023.108073_bib38","first-page":"186","article-title":"Identifying adherent patients to newly initiated statins using previous adherence to chronic medications","volume":"27","author":"Majd","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.pec.2023.108073_bib39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.amjcard.2014.06.009","article-title":"Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event","volume":"114","author":"Muntner","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pec.2023.108073_bib40","first-page":"1146","article-title":"Using previous medication adherence to predict future adherence","volume":"24","author":"Kumamaru","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.pec.2023.108073_bib41","first-page":"494","article-title":"Predicting 1-year statin adherence among prevalent users: a retrospective cohort study","volume":"23","author":"Krumme","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.pec.2023.108073_bib42","first-page":"829","article-title":"Using group-based trajectory modeling to characterize the association of past ACEIs\/ARBs adherence with subsequent statin adherence patterns among new statin users","volume":"61","author":"Majd","year":"2021","journal-title":"JAPhA"},{"key":"10.1016\/j.pec.2023.108073_bib43","article-title":"Motivational interviewing to support medication adherence in adults with chronic conditions: systematic review of randomized controlled trials","author":"Papus","year":"2022","journal-title":"PEC"},{"key":"10.1016\/j.pec.2023.108073_bib44","series-title":"Motivational interviewing: Helping people change","author":"Miller","year":"2012"},{"key":"10.1016\/j.pec.2023.108073_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002749","article-title":"A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence","volume":"3","author":"Easthall","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.pec.2023.108073_bib46","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/dc14-2098","article-title":"Determinants of adherence to diabetes medications: findings from a large pharmacy claims database","volume":"38","author":"Kirkman","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pec.2023.108073_bib47","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/phar.1994","article-title":"Relationships between medication adherence and cardiovascular disease risk factor control in elderly patients with diabetes","volume":"37","author":"Raebel","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pec.2023.108073_bib48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s11096-019-00895-3","article-title":"Exploring variables associated with medication non-adherence in patients with COPD","volume":"41","author":"Jarab","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.pec.2023.108073_bib49","first-page":"54","article-title":"Patient characteristics associated with medication adherence","volume":"11","author":"Rolnick","year":"2013","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.pec.2023.108073_bib50","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension: a review of prevalence, risk factors, impact, and management","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.pec.2023.108073_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137451","article-title":"Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications?","volume":"10","author":"Hedna","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pec.2023.108073_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3953","article-title":"Lay perspectives on hypertension and drug adherence: systematic review of qualitative research","volume":"345","author":"Marshall","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.pec.2023.108073_bib53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/gerona\/glx169","article-title":"Adherence and persistence among statin users aged 65 years and over: a systematic review and meta-analysis","volume":"73","author":"Ofori-Asenso","year":"2018","journal-title":"J Gerontol"}],"container-title":["Patient Education and Counseling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399123004548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399123004548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:48:05Z","timestamp":1760035685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738399123004548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":53,"alternative-id":["S0738399123004548"],"URL":"https:\/\/doi.org\/10.1016\/j.pec.2023.108073","relation":{},"ISSN":["0738-3991"],"issn-type":[{"value":"0738-3991","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trajectories of adherence to ACEI\/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas","name":"articletitle","label":"Article Title"},{"value":"Patient Education and Counseling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pec.2023.108073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108073"}}